Interleukin 12 induction of interferon gamma-dependent protection against malaria
M Sedegah, F Finkelman, S L Hoffman, M Sedegah, F Finkelman, S L Hoffman
Abstract
Intraperitoneal injection of recombinant Interleukin 12 (rIL-12) at 30 ng/day for 5 days beginning 1 to 2 days before sporozoite challenge or administration of a single dose of 150 ng of rIL-122 days before challenge protected 100% of BALB/c mice against challenge with 10(2) Plasmodium yoelii sporozoites. rIL-12-induced protection was eliminated in all mice by administration of a monoclonal antibody against interferon gamma and in 50% of mice by administration of NG-monomethyl-L-arginine, a competitive inhibitor of nitric oxide synthase. rIL-12 protected BALB/c mice treated with cytotoxic anti-CD4 and anti-CD8 monoclonal antibodies, as well as T-cell- and B-cell-deficient severe combined immunodeficiency mice. These data suggest that rIL-12 stimulates non-B, non-T cells to produce interferon gamma that kills intrahepatic parasites by stimulating nitric oxide production. If rIL-12 proves to be well tolerated by humans, our findings support consideration of rIL-12 as an immunoprophylactic against malaria.
References
- Science. 1989 Jun 2;244(4908):1078-81
- J Immunol. 1988 Feb 15;140(4):1022-7
- J Exp Med. 1991 Apr 1;173(4):869-79
- Science. 1991 May 3;252(5006):715-8
- J Immunol. 1991 Jun 1;146(11):3971-6
- J Immunol. 1992 Jan 1;148(1):92-8
- J Immunol. 1992 Jun 1;148(11):3433-40
- Med Clin North Am. 1992 Nov;76(6):1327-55
- J Exp Med. 1993 May 1;177(5):1505-9
- Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6115-9
- Infect Immun. 1994 Sep;62(9):4043-6
- Science. 1986 May 16;232(4752):881-4
- Infect Immun. 1986 Sep;53(3):628-30
- J Exp Med. 1987 Nov 1;166(5):1229-44
- J Immunol. 1987 Dec 15;139(12):4192-5
- Proc Natl Acad Sci U S A. 1988 Jan;85(2):573-6
- J Exp Med. 1989 Sep 1;170(3):827-45
Source: PubMed